Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Background. Kidney transplant recipients (KTRs) are still at risk of severe COVID-19 disease after SARS‑CoV‑2 vaccination, especially when they have limited antibody formation. Our aim was to understand the factors that may limit their humoral response. Methods. Our data are derived from KTRs who we...

Full description

Bibliographic Details
Main Authors: Sophie C. Frölke, BSc, Pim Bouwmans, MD, A. Lianne Messchendorp, MD, PhD, Suzanne E. Geerlings, MD, PhD, Marc H. Hemmelder, MD, PhD, Ron T. Gansevoort, MD, PhD, Luuk B. Hilbrands, MD, PhD, Marlies E.J. Reinders, MD, PhD, Jan-Stephan F. Sanders, MD, PhD, Frederike J. Bemelman, MD, PhD, Hessel Peters-Sengers, PhD, RECOVAC Collaborators*
Format: Article
Language:English
Published: Wolters Kluwer 2022-11-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001397